| Operative risk factors in the metabolic syndrome: is it lipids and high blood pressure or are there direct vascular effects of insulin resistance and obesity? | |
| | |
MedLine Citation:
|
PMID: 17059794 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The metabolic syndrome is associated with an increased risk for cardiovascular disease. Dyslipidemia, high blood pressure, and impaired glucose tolerance, components of the metabolic syndrome, are all clearly atherogenic. Insulin resistance is an important correlate of other risk factors. Excess abdominal fat, as often seen in overweight people and commonly observed in obese individuals, is the single most important central feature of the metabolic syndrome. In addition to insulin resistance, an excess amount of abdominal fat is associated with all the features of metabolic clustering. Adipocytes secrete several peptide hormones that have been related to the metabolic syndrome and related cardiovascular disease. The role of traditional versus novel adipose tissue-related risk factors in the background of atherosclerosis in the metabolic syndrome are discussed. |
| | |
Authors:
|
Olavi Ukkola |
Related Documents
:
|
3043684 - Virgil sydenstricker: special reference to niacin deficiency encephalopathy. 15083594 - Acetyl-coa carboxylase inhibition for the treatment of metabolic syndrome. 1638104 - Autonomic involvement in inherited neuropathies. 499634 - Mauriac syndrome: three cases with retinal angiofluorescein study. 8033474 - Nephrotic syndrome as an unusual paraneoplastic syndrome of hodgkin's disease demonstra... 23522604 - Outcome of univentricular repair in patients with down syndrome. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Current cardiology reports Volume: 8 ISSN: 1523-3782 ISO Abbreviation: Curr Cardiol Rep Publication Date: 2006 Nov |
Date Detail:
|
Created Date: 2006-10-24 Completed Date: 2007-01-09 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100888969 Medline TA: Curr Cardiol Rep Country: United States |
Other Details:
|
Languages: eng Pagination: 427-32 Citation Subset: IM |
Affiliation:
|
Department of Internal Medicine and Biocenter Oulu, University of Oulu, Kajaanintie 50/P.O. Box 5000, Oulu, FIN-90014, Finland. olavi.ukkola@oulu.fi |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Blood Vessels
/
physiopathology Cardiovascular Diseases / etiology* Humans Hypertension / complications Insulin Resistance Lipids / blood Metabolic Syndrome X / blood, complications*, physiopathology Obesity / complications Risk Factors |
| Chemical | |
Reg. No./Substance:
|
0/Lipids |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Nonpharmacologic therapy for hypertension: does it really work?
Next Document: Surgical risk in patients with metabolic syndrome: focus on lipids and hypertension.